Fresh2 Group Limited is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2023. With two certified clinical laboratories in China and one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The Company is entering the business-to-business e-commerce food business with the formation of its wholly-owned subsidiary Fresh2 Technology Inc and the acquisition of Fresh2 Ecommerce Inc.
Company profile
Ticker
FRES
Exchange
Website
CEO
Chang Yu
Employees
Incorporated
Location
Industry (SIC)
Former names
AnPac Bio-Medical Science Co., Ltd.
SEC CIK
FRES stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
27 Mar 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
8-K
Entry into a Material Definitive Agreement
25 Mar 24
20-F/A
2022 FY
Annual report (foreign) (amended)
25 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Fresh2 Group Ltd. Announces Receipt of a Bid Deficiency Notice from Nasdaq
1 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
29 Jan 24
20-F/A
2022 FY
Annual report (foreign) (amended)
9 Jan 24
6-K
Appointment of New Independent Director
15 Dec 23
Transcripts
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2023
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 14.21 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ST Fortune | 14.21 mm | $0.00 |
News
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Mar 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
27 Mar 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
20 Mar 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
20 Mar 24
12 Health Care Stocks Moving In Monday's After-Market Session
18 Mar 24